The Lancet, 1975. ,
French guidelines for the management of adult sickle cell disease: 2015 update]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.5-8, 2015. ,
Associations between Red Cell Polymorphisms and Plasmodium falciparum Infection in the Middle Belt of Ghana, PLoS ONE, vol.208, issue.12, p.112868, 2014. ,
DOI : 10.1371/journal.pone.0112868.s001
Sickle-cell trait and malaria in Africa, Bull World Health Organ, vol.15, pp.3-5837, 1956. ,
Hemolysis in sickle cell disease, Arch Intern Med, 1974. ,
Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases, Blood, vol.28, issue.5, pp.708-733, 1966. ,
SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES, Clinical and Experimental Pharmacology and Physiology, vol.100, issue.9, pp.926-958, 2007. ,
DOI : 10.1001/jama.289.9.1136
Glomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature, Clinical Journal of the American Society of Nephrology, vol.5, issue.5, pp.756-61, 2010. ,
DOI : 10.2215/CJN.08511109
URL : https://hal.archives-ouvertes.fr/hal-00597593
Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease, Transfusion and Apheresis Science, vol.37, issue.3, pp.241-248, 2007. ,
DOI : 10.1016/j.transci.2007.09.005
Current therapy of sickle cell disease, Haematologica, 2006. ,
Blood and marrow transplantation for sickle cell disease: Is less more?, Blood Reviews, vol.28, issue.6, pp.243-251, 2014. ,
DOI : 10.1016/j.blre.2014.08.001
Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival, Clinical Nephrology, vol.58, issue.07, pp.9-15, 2002. ,
DOI : 10.5414/CNP58009
Glomerular function and hyperuricaemia in sickle cell disease., Journal of Clinical Pathology, vol.37, issue.9, pp.1046-1055, 1984. ,
DOI : 10.1136/jcp.37.9.1046
Sickle cell nephropathy: New insights into its pathophysiology, Kidney International, vol.27, issue.5, pp.711-718, 1985. ,
DOI : 10.1038/ki.1985.70
Renal Abnormalities in Sickle Cell Disease, Archives of Internal Medicine, vol.150, issue.3, pp.501-505, 1990. ,
DOI : 10.1001/archinte.1990.00390150015003
Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies, Lancet Lond Engl Feb, vol.281, issue.7644, pp.450-452, 1970. ,
Nature of the Renal Concentrating Defect in Sickle Cell Disease*, Journal of Clinical Investigation, vol.46, issue.3, pp.336-381, 1967. ,
DOI : 10.1172/JCI105535
The renal concentrating mechanism. Anglo-Ger Med Rev Dtsch-Engl Med Rundsch, pp.176-185, 1966. ,
Critical observations on the countercurrent urinary concentration system. II. Anatomophysiological considerations]. Recenti Prog Med, pp.286-304, 1967. ,
The Physiology of Urinary Concentration: An Update, Seminars in Nephrology, vol.29, issue.3, pp.178-95, 2009. ,
DOI : 10.1016/j.semnephrol.2009.03.008
Prevalence and Correlates of Metabolic Acidosis among Patients with Homozygous Sickle Cell Disease, Clinical Journal of the American Society of Nephrology, vol.9, issue.4, pp.648-53 ,
DOI : 10.2215/CJN.09790913
Basic Mechanisms of Urinary Acidification, Medical Clinics of North America, vol.67, issue.4, pp.753-70, 1983. ,
DOI : 10.1016/S0025-7125(16)31175-0
Mechanisms and classification of deranged distal urinary acidification, American Journal of Physiology-Renal Physiology, vol.239, issue.6, pp.515-523, 1980. ,
DOI : 10.1152/ajprenal.1980.239.6.F515
Ammonium transport in the kidney, J Nephrol, vol.23, issue.16, pp.28-34, 2010. ,
The Tubular Reabsorption of Phosphate in Sickle-Cell Nephropathy, Clinical Science, vol.55, issue.5, pp.429-463, 1978. ,
DOI : 10.1042/cs0550429
Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Pediatr Blood Cancer, 2014. ,
Renal Reabsorption of Phosphate in Children with Sickle Cell Anemia, American Journal of Nephrology, vol.19, issue.5, pp.552-556, 1999. ,
DOI : 10.1159/000013518
Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease, West African Journal of Medicine, vol.24, issue.2, pp.120-123, 2005. ,
DOI : 10.4314/wajm.v24i2.28180
Serum Phosphate Abnormalities in Sickle Cell Anemia, Experimental Biology and Medicine, vol.168, issue.2, 1981. ,
DOI : 10.3181/00379727-168-41269
Statius van Eps LW. Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption, Nephron, vol.29, pp.3-4138, 1981. ,
Gout and hyperuricemia associated with sickle-cell anemia. Semin Arthritis Rheum, pp.404-417, 1983. ,
DOI : 10.1016/0049-0172(83)90020-3
Hyperuricemia in sickle cell disease in France]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.13-20, 2012. ,
Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia, The American Journal of Medicine, vol.59, issue.6, pp.796-802, 1975. ,
DOI : 10.1016/0002-9343(75)90465-9
Uric in Sickle Acid Excretion Cell Anemia, JAMA: The Journal of the American Medical Association, vol.215, issue.2, pp.255-263, 1971. ,
DOI : 10.1001/jama.1971.03180150039008
Serum urate concentrations in homozygous sickle cell disease, Journal of Clinical Pathology, vol.34, issue.9, pp.965-974, 1981. ,
DOI : 10.1136/jcp.34.9.965
An analysis of glomerular-tubular balance in the rat proximal tubule, Pfl???gers Archiv European Journal of Physiology, vol.243, issue.Suppl 12, pp.221-228, 1986. ,
DOI : 10.1007/BF00580680
Proximal reabsorption with changing tubular fluid inflow in rat nephrons, Experimental Physiology, vol.83, issue.1, pp.35-48, 1998. ,
DOI : 10.1113/expphysiol.1998.sp004090
The Relation between Serum Phosphorus Levels and Clinical Outcomes after Acute Myocardial Infarction, PLoS ONE, vol.301, issue.3, p.58348, 2013. ,
DOI : 10.1371/journal.pone.0058348.t003
Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults, Journal of the American Society of Nephrology, vol.20, issue.2, pp.397-404, 2009. ,
DOI : 10.1681/ASN.2008020141
Relation of Serum Phosphorus Levels to the Incidence of Atrial Fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study), The American Journal of Cardiology, vol.111, issue.6, pp.857-62, 2013. ,
DOI : 10.1016/j.amjcard.2012.11.045
Phosphate: a novel cardiovascular risk factor, European Heart Journal, vol.42, issue.Suppl 3, pp.1099-101 ,
DOI : 10.1172/JCI46122
Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function, The American Journal of Clinical Nutrition, vol.46, issue.6, pp.1465-70, 2011. ,
DOI : 10.1016/S0026-0495(97)90212-2
Circadian variations in renal excretion of magnesium, calcium, phosphorus, sodium, and potassium during frequent feeding and fasting. Fed Proc, 1966. ,
Hemolysis influence on twenty-two biochemical parameters measurement], Ann Biol Clin, p.2014 ,
[A new axis of phosphate balance control: fibroblast growth factor 23-Klotho]. Néphrologie Thérapeutique, pp.513-522, 2009. ,
Exploring mechanisms of FGF signalling through the lens of structural biology, Nature Reviews Molecular Cell Biology, vol.126, issue.3, pp.166-80, 2013. ,
DOI : 10.1021/bi011000u
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1, American Journal of Physiology-Renal Physiology, vol.297, issue.2, pp.282-291, 2009. ,
DOI : 10.1074/jbc.M601252200
Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism, Annual Review of Physiology, vol.75, issue.1, pp.503-536, 2013. ,
DOI : 10.1146/annurev-physiol-030212-183727
Parathyroid Function in Chronic Kidney Disease: Role of FGF23-Klotho Axis, Contrib Nephrol, vol.180, pp.110-133, 2013. ,
DOI : 10.1159/000346791
FGF23 and Klotho in chronic kidney disease, Current Opinion in Nephrology and Hypertension, vol.22, issue.4, pp.397-404 ,
DOI : 10.1097/MNH.0b013e32836213ee
*FGF-23 and Klotho protein -new markers in chronic kidney disease?]. Pol Merkur Lek Organ Pol Towar Lek, pp.235-243, 2013. ,
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis, Journal of the American Society of Nephrology, vol.22, issue.10, pp.1913-1935, 2011. ,
DOI : 10.1681/ASN.2010121224
FGF23 induces left ventricular hypertrophy, Journal of Clinical Investigation, vol.121, issue.11, pp.4393-408, 2011. ,
DOI : 10.1172/JCI46122DS1
URL : http://www.jci.org/articles/view/46122/files/pdf
Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate, Clin Sci, vol.37, issue.1, pp.23-36, 1969. ,
NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION, The Lancet, vol.306, issue.7929, pp.309-319, 1975. ,
DOI : 10.1016/S0140-6736(75)92736-1
French guidelines for the management of adult sickle cell disease: 2015 update, Rev Médecine Interne, vol.36, issue.5, pp.5-8, 2015. ,
Glomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature, Clinical Journal of the American Society of Nephrology, vol.5, issue.5, pp.756-61, 2010. ,
DOI : 10.2215/CJN.08511109
URL : https://hal.archives-ouvertes.fr/hal-00597593
Elderly Survivors with Homozygous Sickle Cell Disease, New England Journal of Medicine, vol.356, issue.6, pp.642-645, 2007. ,
DOI : 10.1056/NEJMc066547
Sickle cell nephropathy: New insights into its pathophysiology, Kidney International, vol.27, issue.5, pp.711-718, 1985. ,
DOI : 10.1038/ki.1985.70
Prevalence and Correlates of Metabolic Acidosis among Patients with Homozygous Sickle Cell Disease, Clinical Journal of the American Society of Nephrology, vol.9, issue.4, pp.648-53, 2014. ,
DOI : 10.2215/CJN.09790913
Nature of concentrating defect in sickle-cell nephropathy.Microradioangiographic studies, Lancet, vol.1, issue.7644, pp.450-452, 1970. ,
Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia, The American Journal of Medicine, vol.59, issue.6, pp.796-802, 1975. ,
DOI : 10.1016/0002-9343(75)90465-9
Gout and hyperuricemia associated with sickle-cell Anemia, Seminars in Arthritis and Rheumatism, vol.12, issue.4, pp.404-417, 1983. ,
DOI : 10.1016/0049-0172(83)90020-3
Statius van Eps LW. Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption, Nephron, vol.29, pp.3-4138, 1981. ,
Statius van Eps LW. The tubular reabsorption of phosphate in sickle-cell nephropathy, Clin Sci Mol Med, vol.55, issue.5, pp.429-463, 1978. ,
Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Pediatr Blood Cancer, pp.2267-70, 2014. ,
Renal reabsorption of phosphate in children with sickle cell anemia Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease, 552?4. 14 Oladipo OO, pp.120-123, 1999. ,
Serum Phosphate Abnormalities in Sickle Cell Anemia, Experimental Biology and Medicine, vol.168, issue.2, pp.254-262, 1981. ,
DOI : 10.3181/00379727-168-41269
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease, JAMA, vol.305, issue.23, pp.2432-2441, 201115. ,
DOI : 10.1001/jama.2011.826
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study, American Journal of Kidney Diseases, vol.31, issue.4, pp.2208-2226, 2004. ,
DOI : 10.1053/ajkd.1998.v31.pm9531176
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis, Journal of the American Society of Nephrology, vol.15, issue.8, pp.607-624, 1998. ,
DOI : 10.1097/01.ASN.0000133041.27682.A2
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis, New England Journal of Medicine, vol.359, issue.6, pp.584-592, 2008. ,
DOI : 10.1056/NEJMoa0706130
Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients, Transplantation, vol.87, issue.7, pp.1040-1044, 2009. ,
DOI : 10.1097/TP.0b013e31819cd122
NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION, The Lancet, vol.306, issue.7929, pp.309-319, 1975. ,
DOI : 10.1016/S0140-6736(75)92736-1
Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity Measurement : Validation and Clinical Application Studies, Hypertension, vol.26, issue.3 ,
DOI : 10.1161/01.HYP.26.3.485
Pulse wave and arterial elastic property--the principle and the essence of pulse wave velocity method, Kokyu To Junkan, vol.24, issue.5, pp.376-87, 1976. ,
Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography, Journal of the American Society of Echocardiography, vol.15, issue.2, pp.167-84, 2002. ,
DOI : 10.1067/mje.2002.120202
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease, American Journal of Respiratory and Critical Care Medicine, vol.90, issue.6, pp.727-767, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.110.983866
Hemolysis influence on twenty-two biochemical parameters measurement, Ann Biol Clin (Paris), vol.72, issue.3, pp.297-311, 2014. ,
Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate, Clin Sci, vol.37, issue.1, pp.23-36, 1969. ,
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1, American Journal of Physiology-Renal Physiology, vol.297, issue.2 ,
DOI : 10.1074/jbc.M601252200
Le facteur de croissance des fibroblastes 23 et son r??cepteur Klotho, m??decine/sciences, vol.25, issue.5, pp.489-95, 2009. ,
DOI : 10.1051/medsci/2009255489
Effects of Growth Hormone on Phosphocalcium Homeostasis and Bone Metabolism, Hormone Research, vol.44, issue.3, pp.55-63, 1995. ,
DOI : 10.1159/000184675
FGF23 and Klotho in chronic kidney disease, Current Opinion in Nephrology and Hypertension, vol.22, issue.4, pp.397-404, 2013. ,
DOI : 10.1097/MNH.0b013e32836213ee
FGF-23 and Klotho protein -new markers in chronic kidney disease? Pol Tow Lek, pp.235-243, 2013. ,
Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism, Annual Review of Physiology, vol.75, issue.1, pp.503-536, 2013. ,
DOI : 10.1146/annurev-physiol-030212-183727
Klotho and Chronic Kidney Disease, Contrib Nephrol, vol.180, pp.47-63, 2013. ,
DOI : 10.1159/000346778
Un nouveau syst??me de r??gulation du bilan du phosphate??: Fibroblast Growth Factor 23-Klotho, N??phrologie & Th??rapeutique, vol.5, issue.6, pp.513-522, 2009. ,
DOI : 10.1016/j.nephro.2009.04.001
An analysis of glomerular-tubular balance in the rat proximal tubule, Pfl???gers Archiv European Journal of Physiology, vol.243, issue.Suppl 12, pp.221-228, 1986. ,
DOI : 10.1007/BF00580680
Proximal reabsorption with changing tubular fluid inflow in rat nephrons, Experimental Physiology, vol.83, issue.1, pp.35-48, 1998. ,
DOI : 10.1113/expphysiol.1998.sp004090
Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents?, Scandinavian Journal of Urology and Nephrology, vol.24, issue.1 ,
DOI : 10.1093/ndt/gfn306
Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes, Archives of Disease in Childhood, vol.95, issue.2, pp.119-143, 2010. ,
DOI : 10.1136/adc.2009.158394
Hemolysis in Sickle Cell Disease, Archives of Internal Medicine, vol.133, issue.4, pp.624-655, 1974. ,
DOI : 10.1001/archinte.1974.00320160118010
SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES, Clinical and Experimental Pharmacology and Physiology, vol.100, issue.9, pp.926-958, 2007. ,
DOI : 10.1001/jama.289.9.1136
Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases, Blood, vol.28, issue.5, pp.708-733, 1966. ,
Mitochondrial cytochrome c biogenesis: no longer an enigma, Trends in Biochemical Sciences, vol.40, issue.8, pp.446-55, 2015. ,
DOI : 10.1016/j.tibs.2015.05.006
URL : http://europepmc.org/articles/pmc4509832?pdf=render
Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling, Journal of the American Society of Nephrology, vol.26, issue.7, pp.1608-1626, 2015. ,
DOI : 10.1681/ASN.2014010104
Elevated Preoperative Phosphorus Levels Are an Independent Risk Factor for Cardiovascular Mortality, American Journal of Nephrology, vol.32, issue.2, pp.163-171, 2010. ,
DOI : 10.1159/000315856
Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function, The American Journal of Clinical Nutrition, vol.46, issue.6, pp.1465-70, 2011. ,
DOI : 10.1016/S0026-0495(97)90212-2
Phosphate: a novel cardiovascular risk factor, European Heart Journal, vol.42, issue.Suppl 3, pp.1099-101, 2013. ,
DOI : 10.1172/JCI46122
URL : https://academic.oup.com/eurheartj/article-pdf/34/15/1099/17894702/ehs247.pdf
Relation of Serum Phosphorus Levels to the Incidence of Atrial Fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study), The American Journal of Cardiology, vol.111, issue.6, pp.857-62, 2013. ,
DOI : 10.1016/j.amjcard.2012.11.045
Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults, Journal of the American Society of Nephrology, vol.20, issue.2, pp.397-404, 2009. ,
DOI : 10.1681/ASN.2008020141
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis, Journal of the American Society of Nephrology, vol.22, issue.10, pp.1913-1935, 2011. ,
DOI : 10.1681/ASN.2010121224
FGF23 induces left ventricular hypertrophy, Journal of Clinical Investigation, vol.121, issue.11, pp.4393-408, 2011. ,
DOI : 10.1172/JCI46122DS1
URL : http://www.jci.org/articles/view/46122/files/pdf
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease, New England Journal of Medicine, vol.350, issue.9, pp.886-95, 2004. ,
DOI : 10.1056/NEJMoa035477
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease, American Journal of Respiratory and Critical Care Medicine, vol.90, issue.6, pp.727-767, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.110.983866
Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation, Haematologica, vol.94, issue.3, pp.340-347, 2009. ,
DOI : 10.3324/haematol.13812
Pulmonary hypertension and nitric oxide depletion in sickle cell disease, Blood, vol.116, issue.5, pp.687-92, 2010. ,
DOI : 10.1182/blood-2010-02-268193
Pulmonary hypertension, tricuspid regurgitant velocity screening, and the nitric oxide pathway. Hematol Educ Program Am Soc Hematol, pp.419-445, 2011. ,
Vasculopathy and pulmonary hypertension in sickle cell disease, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.277, issue.4, pp.314-338, 2015. ,
DOI : 10.1152/ajpheart.00296.2012
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, issue.3, pp.377-90, 2014. ,
DOI : 10.1182/blood-2013-04-495887
Vasculature and Kidney Complications in Sickle Cell Disease, Journal of the American Society of Nephrology, vol.23, issue.5, pp.781-785, 2012. ,
DOI : 10.1681/ASN.2011101019
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom, British Journal of Haematology, vol.92, issue.Suppl. 6, pp.400-408, 2013. ,
DOI : 10.3324/haematol.10937
Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation, Blood Purification, vol.30, issue.4, pp.277-87, 2010. ,
DOI : 10.1159/000320765
URL : https://hal.archives-ouvertes.fr/hal-01610436
HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application, Clinica Chimica Acta, vol.411, issue.21-22, pp.21-221632, 2010. ,
DOI : 10.1016/j.cca.2010.06.001
Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype, Blood Cells, Molecules, and Diseases, vol.44, issue.4, pp.229-261, 2010. ,
DOI : 10.1016/j.bcmd.2010.02.005
Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity, European Journal of Haematology, vol.365, issue.1, pp.55-61 ,
DOI : 10.1056/NEJMoa1005565
Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress, Blood Cells, Molecules, and Diseases, vol.45, issue.1, p.40, 2010. ,
DOI : 10.1016/j.bcmd.2010.03.004
Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype, Blood Cells, Molecules, and Diseases, vol.44, issue.4, pp.229-261, 2010. ,
DOI : 10.1016/j.bcmd.2010.02.005
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death, British Journal of Haematology, vol.358, issue.Suppl. 1, pp.506-519, 2009. ,
DOI : 10.1161/01.CIR.99.24.3092
CURAMA study group. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis ,
Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease, Annals of Hematology, vol.82, issue.5, pp.282-288, 2005. ,
DOI : 10.1007/s00277-004-0983-3
Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity, European Journal of Haematology, vol.365, issue.1, pp.55-61, 2013. ,
DOI : 10.1056/NEJMoa1005565
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension, The FASEB Journal, vol.19, issue.9, pp.1175-1182, 2005. ,
DOI : 10.1096/fj.04-3223fje
Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme, New England Journal of Medicine, vol.326, issue.14, pp.910-952, 1992. ,
DOI : 10.1056/NEJM199204023261402
A Randomized Trial of Captopril for Microalbuminuria in Normotensive Adults with Sickle Cell Anemia, The American Journal of Medicine, vol.104, issue.4, pp.339-342, 1998. ,
DOI : 10.1016/S0002-9343(98)00056-4